HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

HYPD

Hyperion DeFi, Inc. (NASDAQ)

Healthcare — Biotechnology

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.

Strong Buy 1.0 / 5 2 analysts
$3.14
(0.00%)
Target: $6.95 (121.3%)
Sign in to add HYPD to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$47.60M
P/E Ratio (TTM)-
Forward P/E-
EPS (TTM)$-7.55
Dividend Yield-
Profit Margin-
Revenue Growth1559.50%
ROE-135.26%
Debt/Equity1.02
Recommendation Strong Buy 1.0
Analyst Target$6.95
Analysts2
Indexes NASDAQ

Technical Indicators

RSI (14)63.1
Beta2.48
SMA 20-
SMA 40-
52-Week High$16.35
52-Week Low$2.49
50-Day Avg$3.54
200-Day Avg$4.64
Avg Volume590.2K
Volume491.9K

Performance Analysis

BULLISH

HYPD shows predominantly bullish signals based on its fundamentals and technicals.

+ Trading near its 52-week low ($2.49), which could present a value opportunity.
+ RSI at 63.1 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 1559.5% year-over-year.
+ Wall Street consensus is "Strong Buy" from 2 analysts.
+ Average analyst target of $6.95 implies 121.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:14 UTC

Back to Screener Export Report